In tumors with p-stage I or II, B7-H3 tumor positivity was associated with lower DFS (log-rank P = 0.0002; Figure 3A) and lower overall survival (log-rank P = 0.0018; Figure 3C), whereas in tumors with p-stage III or IV, B7-H3 expression was not associated with DFS (log-rank P = 0.53; Figure 3B) or overall survival (log-rank P = 0.96; Figure 3D). This evidence concerns the gene CD276 and neoplasm.